C3 and lupus nephritis: To our knowledge, this is the first reported case of a heterozygous mutation in the C3 gene, clinically presenting as lupus nephritis, with autoantibodies against complement alternative pathway proteins that induce complement activation, and this fact could explain the tissue damage is restricted to the kidneys.